Breast Cancer

  1. Talzenna
    Talzenna (talazoparib)
    by Pfizer Europe MA EEIG
    for Breast Cancer
    €0.00
  2. Piqray
    Piqray (alpelisib)
    by Novartis
    for Breast Cancer
    €23,736.00
  3. Nerlynx
    Nerlynx (neratinib)
    by Puma biotechnology
    for Breast Cancer
    €6,552.47
  4. Verzenio/Verzenios
    Verzenio/Verzenios (abemaciclib)
    by Lilly
    for Breast Cancer
    €1,732.80
  5. Ibrance
    Ibrance (palbociclib)
    by Pfizer Limited
    for Breast Cancer
    €2,780.00
  6. Kisqali
    Kisqali (ribociclib)
    by Novartis Europharm Limited
    for Breast Cancer
    €2,510.22
  7. Lynparza
    Lynparza (olaparib)
    by AstraZeneca AB
    for Breast Cancer, Gynaecological Cancer
    €6,283.20
  8. Perjeta
    Perjeta (Pertuzumab)
    by Roche Registration Limited
    for Breast Cancer
    €2,834.58
View as Grid List

8 Items

per page
Set Descending Direction